Ledger.Open graph →
SEC Form D · Amendment · filed October 5, 2020

CytoSite BioPharma Inc

Offering
$5.1M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SUDBURY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Richard Smith · Sudbury, MAExecEllen Cordo · Sudbury, MAExecJames Jenson · Sudbury, MAExec · DirectorRobert Gailus · Sudbury, MADirectorMark Mintun · Sudbury, MADirectorStephen Sands · Sudbury, MADirectorMichel Chu · Sudbury, MADirectorJ. A. Martin · St. Louis Park, MNExecRobert E. Buccini · Wilmington, DEDirectorStephen Sands · Sudbury, MADirectorJose M. Padilla · San Antonio, TXExec · DirectorCasey A. Tansey · St. Louis Park, MNExecNelson Schubart · New York, NYDirectorMichael Milstein · New York, NYDirectorDavid Rudd · SAN FRANCISCO, CAExecTom Lockard · SAN FRANCISCO, CAExecJanet D. Ruffing · Traverse City, MIDirectorNicholas D. Gao · Traverse City, MIExec · DirectorRobert Lair · Burlington, VTDirectorFrank Dalton · Gainesville, FLDirectorMark Lowry · Gainesville, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗